Literature DB >> 25729060

The baroreflex as a long-term controller of arterial pressure.

Thomas E Lohmeier1, Radu Iliescu2.   

Abstract

Because of resetting, a role for baroreflexes in long-term control of arterial pressure has been commonly dismissed in the past. However, in recent years, this perspective has changed. Novel approaches for determining chronic neurohormonal and cardiovascular responses to natural variations in baroreceptor activity and to electrical stimulation of the carotid baroreflex indicate incomplete resetting and sustained responses that lead to long-term alterations in sympathetic activity and arterial pressure. ©2015 Int. Union Physiol. Sci./Am. Physiol. Soc.

Mesh:

Substances:

Year:  2015        PMID: 25729060      PMCID: PMC4346703          DOI: 10.1152/physiol.00035.2014

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  65 in total

Review 1.  What does the brain know about blood pressure?

Authors:  S W Mifflin
Journal:  News Physiol Sci       Date:  2001-12

2.  Sustained activation of the central baroreceptor pathway in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Justin R Lohmeier; Susan Warren; Paul J May; J Thomas Cunningham
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

3.  Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Authors:  George L Bakris; Mitra K Nadim; Hermann Haller; Eric G Lovett; Jill E Schafer; John D Bisognano
Journal:  J Am Soc Hypertens       Date:  2012-02-15

4.  Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.

Authors:  Uta C Hoppe; Mathias-Christoph Brandt; Rolf Wachter; Joachim Beige; Lars Christian Rump; Abraham A Kroon; Adam W Cates; Eric G Lovett; Hermann Haller
Journal:  J Am Soc Hypertens       Date:  2012-06-12

5.  Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.

Authors:  Murray D Esler; Henry Krum; Markus Schlaich; Roland E Schmieder; Michael Böhm; Paul A Sobotka
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

Review 6.  Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

7.  Renal responses to chronic suppression of central sympathetic outflow.

Authors:  Radu Iliescu; Eric D Irwin; Dimitrios Georgakopoulos; Thomas E Lohmeier
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

8.  Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.

Authors:  Teba Alnima; Peter W de Leeuw; Frans E S Tan; Abraham A Kroon
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

Review 9.  The sympathetic nervous system in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

10.  Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension.

Authors:  Radu Iliescu; Ionut Tudorancea; Eric D Irwin; Thomas E Lohmeier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

View more
  30 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

Review 2.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 3.  Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.

Authors:  Kristine Chobanyan-Jürgens; Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 4.  [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].

Authors:  M Wallbach; M J Koziolek; R Wachter
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

5.  Preeminent role of the cardiorenal axis in the antihypertensive response to an arteriovenous fistula: an in silico analysis.

Authors:  John S Clemmer; W Andrew Pruett; Robert L Hester; Thomas E Lohmeier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-30       Impact factor: 4.733

Review 6.  Device-Based Approaches for the Treatment of Arterial Hypertension.

Authors:  Jens Jordan
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

7.  Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver.

Authors:  Joana F Sacramento; Maria J Ribeiro; Tiago Rodrigues; Elena Olea; Bernardete F Melo; Maria P Guarino; Rui Fonseca-Pinto; Cristiana R Ferreira; Joana Coelho; Ana Obeso; Raquel Seiça; Paulo Matafome; Sílvia V Conde
Journal:  Diabetologia       Date:  2016-10-16       Impact factor: 10.122

8.  Electrical carotid sinus stimulation may get lost in translation.

Authors:  Jens Jordan; Jens Tank
Journal:  Hypertens Res       Date:  2020-07-22       Impact factor: 3.872

9.  Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension.

Authors:  Casey Y Carmichael; Richard D Wainford
Journal:  Hypertension       Date:  2015-04-20       Impact factor: 10.190

Review 10.  Renal denervation for the treatment of resistant hypertension: review and clinical perspective.

Authors:  Radu Iliescu; Thomas E Lohmeier; Ionut Tudorancea; Luke Laffin; George L Bakris
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.